Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule
VENTNOR CITY, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Unity Consortium recognizes that recent changes to the U.S. childhood and...
Vaccine
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue and 2026 Revenue Guidance and Anticipated Development Milestones
Preliminary total global full year 2025 revenue of approximately $616 million Preliminary BRIUMVI U.S. fourth quarter and full year 2025...
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Nu-Tek Manufacturing Facility Nu-Tek's state-of-the-art facility, purpose built to provide over 2000 metric tons of animal-free production annually. Nu-Tek BioSciences...
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave – NV-387 is Effective Against H3N2
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focusIn future, Evaxion’s proprietary AI-Immunology™ platform...
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
January 13, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company...
Using Recombinant Insulin and Trypsin for Safer Vaccine Production, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how recombinant insulin improves viral production across diverse vaccine platforms. Attendees will gain insight into...
Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors
DEVENS, Mass., Jan. 12, 2026 /PRNewswire/ -- Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced...
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings CallImproves 2025 expected GAAP...
Cellev8 Nutrition Welcomes Dr. Guangshuo “Alan” Zhu, MD to Its Board of Directors
WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant...
Ascend Advanced Therapies – ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice...
BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2026) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or...
Services PMI® at 54.4%; December 2025 ISM® Services PMI® Report
Business Activity Index at 56%; New Orders Index at 57.9%; Employment Index at 52%; Supplier Deliveries Index at 51.8%TEMPE, Ariz., Jan....
Services PMI® at 54.4%; December 2025 ISM® Services PMI® Report
Business Activity Index at 56%; New Orders Index at 57.9%; Employment Index at 52%; Supplier Deliveries Index at 51.8%TEMPE, Ariz., Jan....
Services PMI® at 54.4%; December 2025 ISM® Services PMI® Report
Business Activity Index at 56%; New Orders Index at 57.9%; Employment Index at 52%; Supplier Deliveries Index at 51.8%TEMPE, Ariz., Jan....
Xtalks Announces its Life Science Webinar Calendar for January 2026
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing...
Xtalks Announces its Life Science Webinar Calendar for January 2026
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing...
Xtalks Announces its Life Science Webinar Calendar for January 2026
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing...
Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
Vaxxas HD-MAP Self Administration Vaxxas HD-MAP Self Administration Vaxxas CEO David Peacock Vaxxas CEO David Peacock Vaxxas HD-MAP Vaxxas HD-MAP...
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
COPENHAGEN, Denmark, January 7, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered...